Health News

Drugs that target a single signaling pathway that drives tumor development and/or progression have been developed successfully to treat a few forms of cancer. However, in many cases drugs designed using this approach have not worked. Dario Altieri and colleagues, at the University of Massachusetts Medical School, Worcester, have now addressed this issue by using a combinatorial approach to drug design.

Read more

Filed under: Pharmacy News
Tags: cancer, Drug, Pharmacy, Protein, Tumor

Related posts

• TGen licenses ONCO-101 cancer drug to Syracuse (0)
  The Translational Genomics Research Institute has licensed its first drug, a unique compound that targets cancer tumors by modifying the actions of proteins. Read more [tags] Pharmacy News [/tags]
  
  
• Researchers isolate protein domain linked to tumor progression (0)
  When a promising cancer drug reached clinical trials in the 1990s, researchers were disappointed by the debilitating side effects that limited the trials. Read more [tags] Pharmacy News [/tags]
  
  
• Researchers develop potent new drug that can kill tumor cells (0)
  All cells have the ability to recycle unwanted or damaged proteins and reuse the building blocks as food. But cancer cells have ramped up the system, called autophagy, and rely on it to escape damage in the face of chemotherapy and other treatments. Now, researchers at the Perelman School of Medicine; the Abramson Cancer Center; [...]
  
  
• PTEN does not reduce effectiveness of breast cancer drug, Herceptin: Study (0)
  Contrary to what many oncologists had thought, a tumor suppressor protein known as PTEN does not reduce the effectiveness of the breast cancer drug Herceptin, according to a study by Mayo Clinic and North Central Cancer Research Group investigators. Read more [tags] Pharmacy News [/tags]
  
  
• PIK3CA, KRAS mutations in tumor can predict patients’ response to treatment: Research (0)
  Drugs such as everolimus that target the protein mTOR are used to treat several forms of cancer, but not all patients respond to the treatment. A team of researchers, led by Alberto Bardelli, at the University of Turin Medical School, Italy, has now identified a way to help predict which patients will respond to such [...]